Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% [1], contributing to poor physical and emotional well-being. The most comprehensive systematic review indicates pain prevalence ranging from 33% in patients after curative treatment, to 59% in patients on anticancer treatment and to 64% in patients with metastatic, advanced or terminal disease [2]. Pain has a high prevalence earlier in disease in specific cancer types such as pancreatic (44%) and head and neck cancer (40%) [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 2 The assessment of BTcP. BTcP, breakthrough cancer pain. Reprinted with permission from [116].](https://figures.cochat.ai/paper-figures/ca72788a69f549f1926fbf99429f0118/management-of-cancer-pain-in-adult-patients-esmo-clinical-practice-guidelines-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the recent ESMO guidelines106 are difficult to follow in those countries where the majority of patients experiencing cancer pain live.”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citation
Cited by
Items 301–400 of 954
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
Weme, S. E. H. D. O., Hulskotte, L. M. G., Vervenne, W. L., Imholz, A. L. T., Cremers, R. G. H. M., Taxis, K., Reyners, A. K. L., de Laar, I. R. F. V. B., Jansman, F. G. A., & Benoist, G. E. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01255-1 · Cited by 8
Thota, R. S., Ramanjulu, R., Ahmed, A., Jain, P. N., Salins, N. S., Bhatnagar, S., Chatterjee, A. S., & Bhattacharya, D. (2020) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.285693 · Cited by 9
“For patients who cannot swallow, those with nausea and vomiting, or those at the end of life who are unable to take oral medication because of weakness or debility, parenteral opioid administration should be considered.[27,28]”
BackgroundZayed, S., Lang, P., Mendez, L. C., Read, N. E., Sathya, J., Venkatesan, V., Moulin, D. E., Warner, A., & Palma, D. A. (2021) · BMC Palliative Care · doi:10.1186/s12904-021-00735-0 · Cited by 7
“NSAIDs may also play a role in decreasing the radiation-induced inflammatory response which contributes to mucositis pain [5, 10].”
BackgroundAbou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Smith, A. E., Muralidharan, A., & Smith, M. T. (2022) · Discover Oncology · doi:10.1007/s12672-022-00569-z · Cited by 8
“3), are the mainstay of analgesic therapy [30].”
BackgroundInfluentialLiu, Y., May, B. H., Hyde, A. J., He, Y., Guo, X., Zhang, A. L., Lu, C., Xue, C. C., & Zhang, H. (2023) · Integrative Cancer Therapies · doi:10.1177/15347354231210870 · Cited by 7
Correa‐Morales, J. E., Mantilla‐Manosalva, N., Cardona, X. R., Bedoya‐Muñoz, L. J., Vargas, B. F., León, M., Giraldo‐Moreno, S., Gomezese, O. F., & Salamanca‐Balen, N. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2023.0445 · Cited by 13
“5,6 Complementary and integrative therapies are becoming increasingly popular due to their potential benefits and safety profile.”
Sato, T., Ono, S., Sato, T., Tanaka, R., Kamo, Y., & Suzuki, T. (2024) · Palliative Medicine Reports · doi:10.1089/pmr.2023.0061 · Cited by 8
Efficacy of Multidisciplinary Pain Management for Advanced Cancer Patients
Chen, D. F., Chen, D., Sun, H., You, D., Tang, H., Li, S., Song, P., Xu, S., Guo, L., Sun, L. J., et al. (2025) · Pain Management Nursing · doi:10.1016/j.pmn.2025.01.003 · Cited by 7
Castiglioni, S., Salgueiro‐González, N., Corli, O., Béen, F. M., Bijlsma, L., Boogaerts, T., Kasprzyk‐Hordern, B., Matias, J. P., Hernández, F. J., van Nuijs, A. L. N., et al. (2025) · Water Research · doi:10.1016/j.watres.2025.123938 · Cited by 9
Nakajima, Y., Kuribayashi, K., Tada, A., Nagano, A., Minami, T., Kanehiro, A., & Kijima, T. (2025) · Cancer Control · doi:10.1177/10732748251353327 · Cited by 8
“In such cases, other gabapentinoids such as pregabalin and gabapentin are also widely recommended as alternatives in several clinical guidelines, including those from ASCO, 10 ESMO, 11 and NeuPSIG.”
Bridging Gaps in Cancer Pain Care: Barriers, Solutions, and a Path Forward for Integrated Management
Gentili, M., Cellini, F., Consoletti, L., Maïo, M. D., Fornasari, D., Fortini, G., Krengli, M., Maranzano, E., Natoli, S., Pergolizzi, S., et al. (2025) · Current Oncology · doi:10.3390/curroncol32110610 · Cited by 8
Imai, H., Fumita, S., Harada, T., Noriyuki, T., Gamoh, M., Okamoto, M., Akashi, Y., Kizawa, Y., & Tokoro, A. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa186 · Cited by 7
“Sex Male 55 (80) Female 14 (20) Age category, years <50 1 (1) 50–64 14 (20) 65–74 26 (38) ≥75 28 (41) Admission status Inpatient 47 (68) Outpatient 22 (32) Metastasis 66 (96) ECOG PS 0 4 (6) 1 50 (72) 2 15 (22) Anticancer medications Yes 23 (33) No 46 (67) Bowel movements in past week ≥7 19 (28) 7 16 (23) 3–6 34 (49)…”
BackgroundNebenwirkungen der Immun-Checkpoint-Inhibitor-Therapie urologischer Tumoren
Grimm, M., Gottschlich, T., Ali, N., Foller, S., & Leucht, K. (2021) · Der Urologe · doi:10.1007/s00120-021-01550-4 · Cited by 7
Chu, T. H., Rueter, M., Palmaro, A., & Lapeyre‐Mestre, M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15011 · Cited by 7
“Actually, since the early 2000s, several national guidelines have focused on a better pain management in France with a special focus on patients with cancer and for opioid analgesics,(45,46) in parallel with European guidelines.(1,37,47,48) This favourable evolution may also have been supported by the incentives imple…”
BackgroundHigami, Y., Higuchi, A., Tanaka, H., Moriki, Y., Utsumi, M., Yamakawa, M., Ito, Y., Hatano, Y., Maeda, I., & Fukui, S. (2021) · International Journal of Nursing Practice · doi:10.1111/ijn.13019 · Cited by 7
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain
Fujita, Y., Matsuoka, H., Chiba, Y., Tsurutani, J., Yoshida, T., Sakai, K., Nakura, M., Sakamoto, R., Makimura, C., Ohtake, Y., et al. (2023) · Oncology Letters · doi:10.3892/ol.2023.13941 · Cited by 8
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China
Ma, K., Cheng, Z., Jiang, H., Lin, Z., Liu, C., Liu, X., Lu, L., Lü, Y., Tao, W., Wang, S., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s445171 · Cited by 10
Pain Management in Multiple Myeloma Patients: A Literature Review
Rana, S., Maharjan, S., Sookdeo, S. D., & Schmidt, P. (2024) · Cureus · doi:10.7759/cureus.55975 · Cited by 7
“In addition to traditional opioids, methadone has gained attention for its effectiveness in opioid rotation and its potential as an alternative for MM patients [24].”
BackgroundInfluentialAntonuzzo, A., Gonella, S., Blasi, L., Carnio, S., Franzese, C., Marano, L., Santini, D., & Bossi, P. (2025) · Healthcare · doi:10.3390/healthcare13030212 · Cited by 10
Dzierżanowski, T., & Kozlowski, M. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85943 · Cited by 7
Jufriady Ismy, X., Emril, D. R., & Rizkidawati (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.10.070 · Cited by 7
Montés, A. F., de Velasco, G., Aguín, S., Farriols, C., Guirado-Risueño, M., Guía, V. G. J., Baeza-Nadal, M. V., Chicas-Sett, R., Fírvida, J. L., Navalón, F. J. G., et al. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00816-5 · Cited by 7
Giannitrapani, K. F., Silveira, M. J., Azarfar, A., Glassman, P. A., Singer, S. J., Asch, S. M., Midboe, A. M., Zenoni, M., Gamboa, R., Becker, W. C., et al. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06747-z · Cited by 11
“More than 17 million Americans live with cancer,(1) many with co-morbid pain.(2) In cancer, pain is a distressing and disabling experience;(3) undertreatment is a persistent concern.”
BackgroundOral Methadone for Patients With Neuropathic Pain Due to Neoplastic Brachial Plexopathy
Matsuda, Y., & Okayama, S. (2021) · Journal of Palliative Care · doi:10.1177/08258597211016564 · Cited by 7
Bossi, P., Antonuzzo, A., Armento, G., Consoli, F., Giuliani, J., Giusti, R., Lucchesi, M., Mirabile, A., Palermo, L., & Scagliarini, S. (2021) · Cancer Management and Research · doi:10.2147/cmar.s310651 · Cited by 9
“Oncological pain can be divided into two categories: background pain, which manifests as a persistent pain state usually controlled by long-term analgesic treatment, and breakthrough cancer pain (BTcP), defined as short durations of severe pain intensity that “break through” analgesic coverage.(6,7) BTcP affects nearl…”
BackgroundSelf-citationHigh-rate breakthrough cancer pain and tumour characteristics – literature review and case series
Cuomo, A., Boutis, A. L., Colonese, F., & Nocerino, D. (2023) · Drugs in Context · doi:10.7573/dic.2022-11-1 · Cited by 6
Use of Goals in Cancer Pain Management: A Systematic Review
Ehrlich, O., Lackowski, A., Glover, T. L., & Vallerand, A. H. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.05.026 · Cited by 7
Tuca, A., Viejo, M. Á. N., Maradey, P., Canal-Sotelo, J., Mancilla, P. G., Rivero, S. G., Casillas, I. R., Abián, M. H., & Bermudo, C. L. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06006-1 · Cited by 7
Access to Opioids for Patients with Advanced Disease
Edwards, H. L., & Bennett, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716095337 · Cited by 7
“thoracocentesis), and co-morbid conditions (15).”
BackgroundEstévez, F. V., Alarcón, M. D. L., Babarro, A. A., Gayoso, L. O., de Castro, J., Lería-Gelabert, M., & Klinkas, M. M. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1775073 · Cited by 7
Tegenborg, S., Fransson, P., & Martinsson, L. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2228992 · Cited by 8
“Although the prevalence of pain is high in patients undergoing curative cancer treatment, being found in 40% [4] of them, it is even higher in patients with advanced, metastatic, or terminal cancer, among whom its prevalence is 58–74% [2,5,6].”
BackgroundTransdermal Fentanyl in Patients with Cachexia—A Scoping Review
Carlini, A., Scarpi, E., Bettini, C., Ardizzoni, A., Donati, C. M., Fabbri, L., Ghetti, F., Martini, F., Ricci, M., Sansoni, E., et al. (2024) · Cancers · doi:10.3390/cancers16173094 · Cited by 7
“This recommendation is particularly relevant for patients experiencing conditions common in cachexia, such as nausea, vomiting, swallowing difficulties, constipation, and poor compliance [6,34].”
BackgroundThe Challenge of Managing Neuropathic Pain in Children and Adolescents with Cancer
Coluzzi, F., Stefano, G. D., Scerpa, M. S., Rocco, M., Nardo, G. D., Innocenti, A., Vittori, A., Ferretti, A., & Truini, A. (2025) · Cancers · doi:10.3390/cancers17030460 · Cited by 7
Barnosky, V., Brown, M. R. D., Bagchi, S., Blain, R., Husejnovic, D., Johnson, S., & Mackworth-Praed, M. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1481245 · Cited by 5
Yasukochi, S., Yamakawa, W., Taniguchi, M., Itoyama, S., Tsuruta, A., Kusunose, N., Yamauchi, T., Nakamura, R., Matsunaga, N., Ohdo, S., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1969-24.2025 · Cited by 7
Hasegawa, T., Okuyama, T., Suzuki, N., Furukawa, Y., Tasaki, Y., Iida, M., Ito, A., Uchida, M., Kubota, Y., Kikuchi, S., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf215 · Cited by 6
Liguori, L., Pepe, S., Pagliara, V., Feo, R. D., Ottaiano, A., Perri, F., Polcaro, G., Conti, V., Ferrone, C. R., Sabbatino, F., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-15684-4 · Cited by 6
Mao, D., Luo, Y., Zhang, L., Liu, S., Zhu, B., Yang, Z., Zhao, Y., & Zhang, L. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10137-0 · Cited by 6
“After the administration of a three-step analgesic regimen [41], pain levels gradually abated, although they remained elevated compared to pre-chemotherapy levels.”
Wong, P. K., Wang, L., Ho, M., & Lin, C. (2026) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.70122 · Cited by 7
“The guideline by the European Society for Medical Oncology (ESMO) emphasizes the importance of continuous assessment of cancer pain, as it is crucial for the initiation of an individualized regimen for effective pain management (Fallon et al. 2018).”
Kernick, L., Glare, P. A., Hosie, A., Chiu, A., & Kissane, D. W. (2023) · Palliative & Supportive Care · doi:10.1017/s1478951523000378 · Cited by 9
Pain after cancer: Time to move towards a mechanism‐based approach!
Meeus, M. (2023) · The Anatomical Record · doi:10.1002/ar.25309 · Cited by 6
“…pain after treatment, pain in advanced or palliative cancer, pain in cancer survivors); and emphasizing the need for nonpharmacological treatments (Fallon et al., 2018; Meghani & Vapiwala, 2018; Swarm et al., 2019), appropriate diagnosis and evaluation of the patients is still lacking to enable…”
BackgroundDonati, C. M., Maggiore, C., Maltoni, M. C., Rossi, R., Nardi, E., Zamagni, A., SIEPE, G., Mammini, F., Cellini, F., Rito, A. D., et al. (2023) · Cancers · doi:10.3390/cancers16010109 · Cited by 6
Empowering Cancer Patients with Self-Care and Pain Management Skills: A Quasi-Experimental Study
Bico, I. M. T., Afonso, A., Sousa, L., Bule, M. J., & Lopes, M. J. (2024) · Pain Management Nursing · doi:10.1016/j.pmn.2024.03.001 · Cited by 6
Gravdahl, E., Haugen, D. F., & Fredheim, O. M. S. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08664-3 · Cited by 6
“This is reflected in existing guidelines where the SC route is advocated as the preferred route for parenteral administration [1, 2].”
BackgroundPiazzon, N., Cortet, M., Vérot, E., & Carrouel, F. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104548 · Cited by 7
Kotlińska–Lemieszek, A., Klepstad, P., & Haugen, D. F. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2491743 · Cited by 6
Stringent Control of Opioids: Sound Public Health Measures, but a Step Too Far in Palliative Care?
Pinkerton, C., Mitchell, G. K., & Hardy, J. R. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-0900-5 · Cited by 7
Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis
Kaiser, U., Vehling‐Kaiser, U., Kück, F., Mechie, N.-C., Hoffmann, A. C. O. D. S., & Kaiser, F. (2020) · BMC Palliative Care · doi:10.1186/s12904-020-00648-4 · Cited by 8
Miszczyk, M., Wydmański, J., Kocot-Kępska, M., Malec‐Milewska, M., Dolla, Ł., Miśta, W., Miszczyk, L., Ben-Ailan, M., & Lawrence, Y. R. (2021) · Współczesna Onkologia · doi:10.5114/wo.2021.107689 · Cited by 6
“Although relatively effective, the appropriate use of analgesics and co-analgesics according to the European Society for Medical Oncology guidelines [8] is not always sufficient for optimal pain control [5] and is often associated with adverse effects related mostly to opioids [9].”
BackgroundButcher, B., Hutchings, E., Fazekas, B. S., Clark, K., Rowett, D. S., & Currow, D. C. (2021) · Palliative Medicine · doi:10.1177/02692163211045310 · Cited by 6
“36(1) 71 –80 © The Author(s) 2021 Article reuse guidelines: sagepub.”
Thota, R. S., Ramanjulu, R., Ahmed, A., Jain, P. N., Salins, N. S., Bhatnagar, S., Chatterjee, A. S., & Bhattacharya, D. (2020) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.285692 · Cited by 6
“Renal impairment is not thought to impair clearance hence methadone is useful in the management of pain in patients with renal failure.[32] However, patients should be monitored closely for signs of drug toxicity.”
BackgroundQuality Assessment of Cancer Pain Clinical Practice Guidelines
Zhang, Z., Cao, X. Q., Wang, Q., Yang, Q., Sun, M., Ge, L., & Tian, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.890951 · Cited by 7
Michael, N. G., Sulistio, M., Wojnar, R., & Gorelik, A. (2023) · BMC Palliative Care · doi:10.1186/s12904-023-01160-1 · Cited by 6
“Use of adjuvant co-analgesic medications such as NSAID, trazodone, acetaminophen, or Tramadol [15] are permitted but titration of these medications will be restricted during the study period to ensure the observed changes in pain intensity is attributable only to the study intervention.”
BackgroundAdapting psychedelic medicine for headache and chronic pain disorders
Schindler, E. A. D., & Hendricks, P. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2246655 · Cited by 9
“Fully managing chronic pain also involves targeting the underlying disorder and suppressing the generation of pain through preventive measures, which include such varied methods as daily medications (e.g. gabapentinoids), interventional procedures (e.g. radiofrequency ablation), neuromodulation (e.g. vagus nerve stimu…”
BackgroundInfluentialBreakthrough and Episodic Cancer Pain from a Palliative Care Perspective
Løhre, E. T., Jakobsen, G., Solheim, T. S., Klepstad, P., & Thronæs, M. (2023) · Current Oncology · doi:10.3390/curroncol30120746 · Cited by 10
“Patient-reported PI is regarded as the standard for pain assessment and the first necessary step towards effective and individualized pain treatment [13,38].”
BackgroundInfluentialTargeting Pannexin-1 Channels: Addressing the ‘Gap’ in Chronic Pain
McAllister, B. B., Stokes-Heck, S., Harding, E. K., van den Hoogen, N. J., & Trang, T. (2024) · CNS Drugs · doi:10.1007/s40263-024-01061-8 · Cited by 6
“For instance, opioid medications provide potent pain-relief from acute [23] and cancer-related pain [24–26], but their efficacy in people with chronic pain conditions is not well established [21, 27, 28].”
Xiao, X., Sun, J., Zhang, D., Li, L., Zhou, H., Li, Y., Li, Q., He, Z., Fu, Y., Duan, Q., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s451698 · Cited by 6
“7 Due to the rapid metabolism of IR morphine and its short efficacy duration, it must be administered repeatedly with evaluation for at least 24 hours when used in patients with moderate to severe cancer pain.”
BackgroundMethodThe use of interventional procedures for cancer pain. A brief review
Lee, Y.-C., Brake, T., Zhao, E., Dumitrescu, A., Lee, W., Tassie, B., Khor, K. E., & Wang, A. Y.-Y. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08467-6 · Cited by 6
“Cancer pain can be attributed to the malignancy, its complications, or side effects of treatments (e.g., post-surgical pain and chemotherapy-induced peripheral neuropathy) [3, 4].”
BackgroundRole of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain
Wang, Y., & Xing, L. (2020) · Pain Research and Management · doi:10.1155/2020/7565962 · Cited by 6
“It was stated in the European Society for Medical Oncology (ESMO) clinical practice guidelines in 2018 that palliative radiotherapy and targeted therapy should be combined with analgesics for treating bone pain [16].”
BackgroundRadiosurgical hypophysectomy in cancer pain treatment. Literature review and clinical case
Голанов, А. В., Kostjuchenko, V. V., Antipina, N., Isagulyan, E. D., Makashova, E., Abuzarova, G. R., Astafyeva, L. I., Savateev, A. N., & Asriyants, S. (2020) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202084051102 · Cited by 6
Mayoral, V. (2022) · Pain Management · doi:10.2217/pmt-2021-0094 · Cited by 7
Ding, H., Song, Y. K., Wu, N., Zheng, X., Wei, Q., Sun, Y., Xie, R., Zhai, Q., Xu, S., Qi, Y., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4091 · Cited by 6
Tuan, J., Wang, E. H., Leon, J. R. C. D., Mendoza, M. J., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.35770 · Cited by 6
“It notes a role for tramadol in this multimodal approach [2].”
BackgroundInfluentialMercadente, S. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy327 · Cited by 6
Modeling cancer pain: “the times they are a-changin’”
Lemaire, A. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04832-y · Cited by 6
Causes and management of acute oncological pain: a narrative review
Laycock, H. C., Ramdin, C., Grayer, J., & Brown, M. R. D. (2025) · Anaesthesia · doi:10.1111/anae.16512 · Cited by 7
Pérez, F. J. C., Pérez‐Baena, M. J., Pina-Ruviralta, N., Testa, A. F., & Holgado-Madruga, M. (2026) · Healthcare · doi:10.3390/healthcare14040457 · Cited by 10
“However, their effectiveness in managing cancer pain is limited [low certainty, conditional recommendation], with over 50% of patients requiring a transition to strong opioids within two weeks due to inadequate pain control [37,46,52].”
InfluentialPickering, G. P., Capriz, F., Morel, V., Caër, F. L., Guillaumé, C., Floccia, M., Navez, M., Mailland, V., Grégoire, C., de Montgazon, G. B., et al. (2021) · Douleur et Analgésie · doi:10.3166/dea-2021-0182 · Cited by 7
Neurological pain relief interventional radiology procedures
Tan, E., Wang, M. Q. W., Leong, S., Chou, H., & Too, C. W. (2022) · Clinical Radiology · doi:10.1016/j.crad.2022.03.026 · Cited by 5
Zhou, D.-F., Jian-cheng, R., Shu-zhen, Z., Zhang, K., Yang, H., Lian-sheng, Y., & Tang, C. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1163990 · Cited by 5
Macharia, J. M., Raposa, B. L., Sipos, D., Melczer, C., Tóth, Z., & Káposztás, Z. (2023) · Healthcare · doi:10.3390/healthcare11222954 · Cited by 15
“Importantly, pain can be physical, but it can also have psychosocial and spiritual elements since it is whatever the person who experiences it claims it is and occurs whenever they say it does [9].”
BackgroundInfluentialShinkai, M., Katsumata, N., Kawai, S., Kuyama, S., Sasaki, O., Yanagita, Y., Yoshida, M., Uneda, S., Tsuji, Y., Harada, H., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08242-z · Cited by 5
Liang, Y., Jing, P., Gu, Z., Shang, L., Ge, P., Zhang, Y., Wang, L., Qiu, C., Zhu, X., & Tan, Z. (2024) · Trials · doi:10.1186/s13063-024-07963-8 · Cited by 5
“In addition to the target symptoms, if the participants have other novel symptoms or their ePRO exceeds the threshold, standard treatment suggestions designed by the lung cancer specialist will emerge on the WeChat ePRO interactive interface [33–38].”
BackgroundNursPainPrevent: A Prospective Observational Study on Pain During a Bed Bath
Lombart, B., Cimerman, P., Guiot, C., Gayet, V., Sanglier, I. S., Sansac, M., Avignon, S., Boulet, E., Lay, F., Geoffroy, L. T., et al. (2024) · Pain Management Nursing · doi:10.1016/j.pmn.2024.07.009 · Cited by 5
Pojskić, M., Naderi, S., Vaishya, S., Zileli, M., Costa, F., Sharif, S. Y., & Gokaslan, Z. L. (2024) · Neurosurgical Review · doi:10.1007/s10143-024-03050-3 · Cited by 5
“First-choice alternative route for patients unable to receive opioids by oral is s.c. route (morphine, diamorphine and hydromorphone) [49, 50].”
Wang, Y., Xu, Q., Li, Y., Su, Y., Wang, L., Wang, X., Ge, J., Jing, H., Guo, Y., Chen, Y., et al. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.12.002 · Cited by 11
Pan, J., Khan, A. A., Yu, W.-K., & Rui, L. (2025) · BMC Palliative Care · doi:10.1186/s12904-025-01752-z · Cited by 5
“Opioids may reduce cough frequency by only 30–50% in cancer patients, but their use is often limited by significant side effects such as constipation, sedation, opioid toxicity, and opioid-induced hyperalgesia [17, 18].”
Cancer pain – all change please?
Yri, O. E., & Laird, B. J. A. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100341 · Cited by 5
“5 This guidance emphasises a multidisciplinary approach tailored to individual patient needs.”
Saito, T., Shikama, N., Yorozu, A., Kubota, H., Murotani, K., Yamaguchi, K., Oya, N., & Nakamura, N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.07.003 · Cited by 5
Lin, R., Zhu, J., Luo, Y., Lv, X., Lu, M., Chen, H., Zou, H., Zhang, Z., Lin, S., Wu, M., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7034 · Cited by 5
Nakatani, T., Shiosakai, K., Hashimoto, T., Shionoya, M., Akasaka, T., Toyama, K., Ishizuka, H., & Saito, Y. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0289 · Cited by 5
Tegenborg, S., Fransson, P., & Martinsson, L. (2023) · BMC Nursing · doi:10.1186/s12912-023-01227-7 · Cited by 5
“Many observational scales exist for patients who can no longer selfreport [7, 8], but none have been specifically developed for or evaluated for patients with cancer [3, 9].”
BackgroundKnowledge, Perception and Barriers to Cancer Pain Management among Doctors in Malaysia
Yi, K. T., Hui, Y. C., Keat, C. H., & Ahmad, F. (2023) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2023.30.3.17 · Cited by 5
Bianchi, S. P., Faccenda, V., Pacifico, P., Parma, G., Saufi, S., Ferrario, F., Belmonte, M., Sala, L., Ponti, E. D., Panizza, D., et al. (2023) · Medical Oncology · doi:10.1007/s12032-023-02238-9 · Cited by 5
Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits
Cuomo, A. (2023) · Drugs in Context · doi:10.7573/dic.2023-10-2 · Cited by 7
“55,68,69 To provide optimal relief, access to multi-disciplinary teams with expertise in all these treatments is essential.”
BackgroundMethodInfluentialSehgal, A., Noronha, V., Ramaswamy, A., Kumar, A., Pillai, A., Rao, A. R., Kumar, S., Gattani, S. C., Castelino, R., Dhekale, R., et al. (2023) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_326_23 · Cited by 5
Евгеньевич, Г. В., Анисимов, М. А., Ryabukhina, Y. E., Oskolkov, A. V., & Zeynalova, P. A. (2024) · MD-Onco · doi:10.17650/2782-3202-2024-4-1-78-84 · Cited by 5
Wang, W. J., Shi, Q., Cao, Y., Fan, B., & Yang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34522 · Cited by 5
Waldron, D., Levins, K. J., Murphy, D., McCarthy, M., Gorey, D., Ryan, K., Mannion, E. M., Nicholas, B. M., Brannagáin, D. Ó., Reilly, L., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01642-w · Cited by 7
“…divergence of visceral input within the CNS.” SCP “ is easily localized , stabbing or boring in character , and movement-dependent” [28, 29] Fallon et al. [45], describe, “Nociceptive: caused by ongoing tissue damage , either somatic (such as bone pain) or visceral (such as gut or hepatic pain);””
Tung, S., Coburn, N. G., Davis, L., Mahar, A. L., Myrehaug, S. D., Zhao, H., Earle, C. C., Nathens, A. B., & Hallet, J. I. (2019) · British journal of surgery · doi:10.1002/bjs.11330 · Cited by 5
The Roles of Battlefield Acupuncture and Electroacupuncture in a Patient with Cancer-Related Pain
Irman, & Helianthi, D. R. (2020) · Medical Acupuncture · doi:10.1089/acu.2020.1423 · Cited by 5
Opioid-Induced Constipation and Acupuncture: A Case Discussion
Olson, E. A., Metzger, A. K., Mallory, M. J., & Mackey, R. M. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.01.135 · Cited by 5
Kiani, C. S., & Hunt, R. W. (2021) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2020.1852357 · Cited by 5
“European Society of Medical Oncology Clinical Practice Guidelines (10) Gabapentin, pregabalin, duloxetine and TCA are strongly recommended as single agents for first-line treatment.”
BackgroundManagement of cancer pain: challenging the evidence of the recent palliative care opioid guidelines
Kurita, G. P., & Sjøgren, P. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16136 · Cited by 11
Villarroel, P. G., Gumà, J., Marquina, G., Martínez-Jáñez, N., González, E. E., Antón, A., Sánchez, M. B., Cáceres, A. R., López‐López, R., Cornejo, R. A. E., et al. (2022) · Future Oncology · doi:10.2217/fon-2022-0758 · Cited by 5
Arsenijević, T., Stepanović, A., Maračić, B. M., Poparić‐Bandjur, B., Mišković, I., Gavrilović, D., & Nikitović, M. (2023) · Cancer Medicine · doi:10.1002/cam4.6231 · Cited by 5
Giusti, R., Mazzotta, M., Filetti, M., Daniele, G., Tsukuura, H., Ficorella, C., Porzio, G., Marchetti, P., & Verna, L. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-4663-1 · Cited by 5
Self-citationBandieri, E., Potenza, L., Efficace, F., Bruera, E. D., & Luppi, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197097 · Cited by 5
“grade of recommendation of II, C, respectively [17].”
BackgroundImai, H., Fujita, Y., Hiruta, E., Masuno, T., Yamazaki, S., Tanaka, H., Kamiya, T., Sandoh, M., Takei, S., Arai, K., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14557 · Cited by 5
“Opioids are widely used as the standard treatment for moderate-to-severe cancer pain.(3,4) These drugs effectively treat cancer pain but are often limited by adverse effects that negatively impact the quality of life, sometimes leading to their discontinuation.”
Background
Metadata
- Authors
- Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I.
- Affiliations
- Edinburgh Cancer Research (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of L'Aquila (IT)
- Mount Vernon Cancer Centre (GB)
- RWTH Aachen University (DE)
- Walton Centre (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv166-iv191
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2834719472
- Cited by
- 954
- References
- 184
- Citations by year
- 2026: 136 · 2025: 140 · 2024: 143 · 2023: 123 · 2022: 129 · 2021: 126 · 2020: 88 · 2019: 61 · 2018: 6
- FWCI
- 103.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Marie Curie (MCCC-RP-12-A14197, MCCC-RP-15-A18862, MCCC-RP-15-A19005)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
- Keywords
- cancer pain, pain management, advanced cancer, metastatic cancer, terminal cancer, pain prevalence, palliative care, analgesia
- MeSH terms
- Cancer Pain, Cancer Survivors, Pain, Procedural, Procedural Pain, Adult, Analgesics, Opioid, Antineoplastic Combined Chemotherapy Protocols, Europe, Humans, Medical Oncology, Neoplasm Staging, Neoplasms, Pain Measurement, Societies, Medical, Terminal Care, Prevalence, Treatment Outcome, Breakthrough Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.